BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bansal VK, Herzog CA, Sarnak MJ, Choi MJ, Mehta R, Jaar BG, Rocco MV, Kramer H. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report. American Journal of Kidney Diseases 2017;70:859-68. [DOI: 10.1053/j.ajkd.2017.08.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Steckman DA, Adelstein EC, Schulman-Marcus J, Loka A, Mathew RO, Venditti FJ, Sidhu MS. Oral Anticoagulation for Atrial Fibrillation Thromboembolism Prophylaxis in the Chronic Kidney Disease Population: the State of the Art in 2019. Cardiovasc Drugs Ther 2019;33:481-8. [PMID: 31165356 DOI: 10.1007/s10557-019-06885-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
2 Hu A, Niu J, Winkelmayer WC. Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation. Semin Nephrol 2018;38:618-28. [PMID: 30413255 DOI: 10.1016/j.semnephrol.2018.08.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
3 Wetmore JB, Roetker NS, Yan H, Reyes JL, Herzog CA. Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation. Stroke 2020;51:2364-73. [DOI: 10.1161/strokeaha.120.028934] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
4 Di Lullo L, Tripepi G, Ronco C, De Pascalis A, Barbera V, Granata A, Russo D, Di Iorio BR, Paoletti E, Ravera M, Fusaro M, Bellasi A. Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data. J Nephrol 2018;31:751-6. [PMID: 29882198 DOI: 10.1007/s40620-018-0501-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
5 Genovesi S, Slaviero G, Porcu L, Casu G, Bertoli S, Sagone A, Pieruzzi F, Rovaris G, Buskermolen M, Danna P, Montoli A, Oreglia J, Contaldo G, Mazzone P. Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population. International Journal of Cardiology 2018;262:38-42. [DOI: 10.1016/j.ijcard.2018.03.083] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
6 Starr JA, Pinner NA, Mannis M, Stuart MK. A Review of Direct Oral Anticoagulants in Patients With Stage 5 or End-Stage Kidney Disease. Ann Pharmacother 2021;:10600280211040093. [PMID: 34459281 DOI: 10.1177/10600280211040093] [Reference Citation Analysis]
7 Airy M, Schold JD, Jolly SE, Arrigain S, Bansal N, Winkelmayer WC, Nally JV Jr, Navaneethan SD. Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation. Am J Nephrol 2018;48:36-45. [PMID: 30048961 DOI: 10.1159/000491023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Defoe K, Wichart J, Leung K. Time in Therapeutic Range Using a Nomogram for Dose Adjustment of Warfarin in Patients on Hemodialysis With Atrial Fibrillation. Can J Kidney Health Dis 2021;8:20543581211046079. [PMID: 34552757 DOI: 10.1177/20543581211046079] [Reference Citation Analysis]
9 Bilha SC, Burlacu A, Siriopol D, Voroneanu L, Covic A. Primary Prevention of Stroke in Chronic Kidney Disease Patients: A Scientific Update. Cerebrovasc Dis 2018;45:33-41. [PMID: 29316564 DOI: 10.1159/000486016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Reilly RF, Jain N. Warfarin in nonvalvular atrial fibrillation-Time for a change? Semin Dial 2019;32:520-6. [PMID: 31209952 DOI: 10.1111/sdi.12829] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Chen Y, Zhan X, Zhao Q, Wei X, Xiao J, Yan C, Zhang W. Serum lipoprotein(a) and risk of hemorrhagic stroke among incident peritoneal dialysis patients: a large study from a single center in China. Ren Fail 2019;41:800-7. [PMID: 31498021 DOI: 10.1080/0886022X.2019.1659151] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Nigwekar SU, Thadhani R. Long-Term Anticoagulation for Patients Receiving Dialysis: Tilting the Benefit-to-Risk Ratio? Circulation 2018;138:1530-3. [DOI: 10.1161/circulationaha.118.037091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
13 Shroff GR, Stoecker R, Hart A. Non-Vitamin K-Dependent Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With CKD: Pragmatic Considerations for the Clinician. Am J Kidney Dis 2018;72:717-27. [PMID: 29728318 DOI: 10.1053/j.ajkd.2018.02.360] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
14 You X, Zhou Y, Zhang J, Zhou Q, Shi Y, Su Z, Chen C, Shao R, Zhang J. Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis. BMC Nephrol 2020;21:183. [PMID: 32423377 DOI: 10.1186/s12882-020-01817-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Bowie M, Valencia V, Perez-alvarez I, Tran M. Safety analysis of apixaban versus warfarin in patients with advanced kidney disease. J Thromb Thrombolysis 2018;46:246-52. [DOI: 10.1007/s11239-018-1683-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
16 Findlay M, MacIsaac R, MacLeod MJ, Metcalfe W, Sood MM, Traynor JP, Dawson J, Mark PB. The Association of Atrial Fibrillation and Ischemic Stroke in Patients on Hemodialysis: A Competing Risk Analysis. Can J Kidney Health Dis 2019;6:2054358119878719. [PMID: 31632680 DOI: 10.1177/2054358119878719] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
17 Shawwa K, Kompotiatis P, Bobart SA, Mara KC, Wiley BM, Jentzer JC, Kashani KB. New-onset atrial fibrillation in patients with acute kidney injury on continuous renal replacement therapy. J Crit Care 2021;62:157-63. [PMID: 33383309 DOI: 10.1016/j.jcrc.2020.12.010] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]